Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Structure-activity relationships between the Aconitum C20-diterpenoid alkaloid derivatives and the growth suppressive activities of Non-Hodgkins lymphoma Raji cells and human hematopoietic stem/progenitor cells
Investigational New Drugs, 10/08/09
Hazawa M et al. – The atisine type structure characteristic of C20–diterpenoid alkaloids plays a very important role in the pharmacological properties. In particular, the C–11 residues are an important component for the anti–tumor properties and for the lower toxicity to hematopoiesis.
Today in Alternative Therapies...keeping you current
Receive free subspecialty "5-minute updates" via email
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/18/09
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions
Cancer Prevention Research, 11/09/09
Oral Cancer Prevention Advances with a Translational Trial of Green Tea
Cancer Prevention Research, 11/11/09
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Serum calcium levels are elevated among women with untreated postmenopausal breast cancer
Cancer Causes and Control, 11/03/09
Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase III study
Journal of Clinical Oncology, 10/29/09
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


